Guo Qianqian, Liu Liwei, Chen Zelong, Fan Yannan, Zhou Yang, Yuan Ziqiao, Zhang Wenzhou
Department of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, China.
Department of Pharmacy, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Oncol. 2022 Aug 11;12:945102. doi: 10.3389/fonc.2022.945102. eCollection 2022.
Despite improved methods of diagnosis and the development of different treatments, mortality from lung cancer remains surprisingly high. Non-small cell lung cancer (NSCLC) accounts for the large majority of lung cancer cases. Therefore, it is important to review current methods of diagnosis and treatments of NSCLC in the clinic and preclinic. In this review, we describe, as a guide for clinicians, current diagnostic methods and therapies (such as chemotherapy, chemoradiotherapy, targeted therapy, antiangiogenic therapy, immunotherapy, and combination therapy) for NSCLC.
尽管诊断方法有所改进且出现了不同的治疗方法,但肺癌的死亡率仍然高得惊人。非小细胞肺癌(NSCLC)占肺癌病例的绝大多数。因此,回顾临床和临床前NSCLC的当前诊断方法和治疗方法很重要。在本综述中,我们描述了NSCLC的当前诊断方法和治疗方法(如化疗、放化疗、靶向治疗、抗血管生成治疗、免疫治疗和联合治疗),作为临床医生的指南。